U.S. Physical Therapy, Inc. (NYSE:USPH) – Research analysts at Jefferies Financial Group dropped their Q2 2021 earnings estimates for U.S. Physical Therapy in a report issued on Monday, May 3rd. Jefferies Financial Group analyst B. Tanquilut now expects that the company will post earnings per share of $0.74 for the quarter, down from their prior forecast of $0.85. Jefferies Financial Group has a “Buy” rating and a $135.00 price objective on the stock. Jefferies Financial Group also issued estimates for U.S. Physical Therapy’s Q3 2021 earnings at $0.71 EPS, Q4 2021 earnings at $0.75 EPS, Q1 2022 earnings at $0.68 EPS, Q2 2022 earnings at $0.76 EPS, Q3 2022 earnings at $0.73 EPS, Q4 2022 earnings at $0.77 EPS, Q1 2023 earnings at $0.67 EPS and FY2023 earnings at $3.27 EPS.
U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, February 25th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. U.S. Physical Therapy had a return on equity of 11.20% and a net margin of 7.21%. The firm had revenue of $117.47 million during the quarter, compared to analyst estimates of $118.08 million.
Shares of U.S. Physical Therapy stock opened at $116.06 on Tuesday. The business has a fifty day simple moving average of $111.40 and a two-hundred day simple moving average of $114.39. The firm has a market capitalization of $1.50 billion, a P/E ratio of 49.39 and a beta of 1.45. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 0.03. U.S. Physical Therapy has a 12 month low of $64.30 and a 12 month high of $143.67.
Several hedge funds and other institutional investors have recently bought and sold shares of USPH. Copeland Capital Management LLC bought a new stake in U.S. Physical Therapy during the 1st quarter valued at about $14,717,000. BlackRock Inc. grew its stake in U.S. Physical Therapy by 3.9% in the fourth quarter. BlackRock Inc. now owns 2,207,762 shares of the company’s stock worth $265,483,000 after purchasing an additional 82,171 shares in the last quarter. GW&K Investment Management LLC purchased a new position in U.S. Physical Therapy during the 4th quarter worth $6,902,000. Boston Trust Walden Corp increased its holdings in U.S. Physical Therapy by 15.5% during the 4th quarter. Boston Trust Walden Corp now owns 371,229 shares of the company’s stock worth $44,640,000 after purchasing an additional 49,718 shares during the period. Finally, Riverbridge Partners LLC raised its position in U.S. Physical Therapy by 10.3% during the 4th quarter. Riverbridge Partners LLC now owns 384,168 shares of the company’s stock valued at $46,196,000 after purchasing an additional 35,879 shares in the last quarter.
In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 1,600 shares of the business’s stock in a transaction on Monday, March 15th. The shares were sold at an average price of $121.73, for a total value of $194,768.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Harry S. Chapman sold 1,000 shares of the company’s stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $120.82, for a total transaction of $120,820.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,800 shares of company stock valued at $1,246,748. 2.00% of the stock is currently owned by insiders.
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 9th. Investors of record on Friday, March 12th were given a dividend of $0.35 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.32. The ex-dividend date was Thursday, March 11th. This represents a $1.40 dividend on an annualized basis and a yield of 1.21%. U.S. Physical Therapy’s dividend payout ratio is 49.65%.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Article: Cost of Equity For A Business, Investors
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.